About a year ago, Anna DeLaRosby, PT, DPT, had a question for her former classmates from physical therapy school. A 2008 graduate of Clarke University, she had gone on to work at several different clinics and to become a physical therapy instructor herself.
By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Weighty Matters: Physical Therapy and GLP-1 Medications
What PTs need to know about working with patients taking glucagon-like peptide-1 agonists.
Date: Friday, August 1, 2025
Author:
Chris Hayhurst
Share This
Resource Details
Date: August 1, 2025
Contact: aptamag@apta.org
Content Type: Feature
Author(s)
Chris Hayhurst
You Might Also Like...
News
APTA Practice Advisory on AI-Enabled Ambient Scribe Technology Now AvailableSep 19, 2025
The advisory outlines documentation responsibilities and legal and regulatory considerations for this emerging technology.
Article
Advancing the Role of PTs in Falls Prevention Together: From Congress to ClinicsSep 15, 2025
Through advancing evidence-based care, community education about the importance of prevention, and coordinated advocacy around federal legislation, PTs,
News
The Clock Is Ticking for Congress to Extend Medicare Telehealth WaiversSep 9, 2025
Congress must act by Sept. 30 to extend current telehealth access for PTs, PTAs, and other therapy providers.